Page 1 of 6 UnitedHealth Group Reports Third Quarter 2023 Results • Revenues of $92.4 Billion Grew 14% Year-Over-Year • Earnings from Operations Grew 14% • Cash Flows from Operations were $6.9 Billion • Earnings were $6.24 Per Share, Adjusted Earnings $6.56 Per Share (October 13, 2023) UnitedHealth Group (NYSE: UNH) reported third quarter 2023 performance led by broad-based growth at Optum and UnitedHealthcare. “As a result of our colleagues’ steadfast focus on helping people access and receive the care they need, we are well-positioned to help even more people and continue to generate strong, diversified growth in the coming years,” said Andrew Witty, chief executive officer of UnitedHealth Group. Growth in the third quarter was driven by the continuing increase in the number of people served by Optum and UnitedHealthcare and the broadening scope of services offered. The company strengthened the range of its full year 2023 net earnings outlook to $23.60 to $23.75 per share and adjusted net earnings to $24.85 to $25.00 per share. -- 1 of 13 -- Page 2 of 6 Quarterly Financial Performance Three Months Ended September 30, 2023 September 30, 2022 June 30, 2023 Revenues $92.4 billion $80.9 billion $92.9 billion Earnings from Operations $ 8.5 billion $ 7.5 billion $ 8.1 billion Net Margin 6.3% 6.5% 5.9% • UnitedHealth Group’s third quarter 2023 revenues grew 14% to $92.4 billion year-over-year, including double-digit growth at both Optum and UnitedHealthcare. Third quarter 2023 earnings from operations were $8.5 billion, an increase of 14%. • The third quarter 2023 medical care ratio of 82.3%, compared to 81.6% last year, driven by previously noted outpatient care, primarily serving seniors, and business mix. Days claims payable were 50.7, compared to 48.2 in the second quarter 2023 and 50.8 in the third quarter 2022. Favorable medical reserve development of $720 million compared to $480 million in the second quarter 2023 and $870 million in the year-ago third quarter. • The third quarter 2023 operating cost ratio of 15% increased from 14.4% last year as the company’s business mix continues to shift to services and due to investments to support growth, offset in part by productivity improvements. • Cash flows from operations for the third quarter 2023 were $6.9 billion or 1.1x net income. Nine-months to date, cash flows were $34.3 billion or 2.0x net income and adjusted for CMS payment timing were $22.4 billion or 1.3x net income. The company returned over $11.5 billion to shareholders through the first nine months of 2023 through dividends and share repurchases. Return on equity of 28% in the quarter reflected the company’s consistent, broad- based earnings and efficient capital structure. -- 2 of 13 -- Page 3 of 6 UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by improving health and wellness, enhancing the quality of care received, simplifying the health care experience and reducing the total cost of care. Quarterly Financial Performance Three Months Ended September 30, 2023 September 30, 2022 June 30, 2023 Revenues $69.9 billion $62.0 billion $70.2 billion Earnings from Operations $ 4.6 billion $ 3.8 billion $ 4.4 billion Operating Margin 6.6% 6.1% 6.2% • UnitedHealthcare third quarter revenues grew 13% to $69.9 billion, reflecting growth in the number of people served. Operating earnings were $4.6 billion compared to $3.8 billion last year. • Year-to-date, total people served by UnitedHealthcare with medical benefits has increased by 1.1 million, driven by growth in the company’s commercial and public sector businesses. The number of consumers served with commercial benefits has grown by nearly 700,000 in 2023, reflecting the company’s focus on innovative and affordable benefit plans. The number of people served by the company’s senior and community offerings grew by over 400,000 due to product designs tailored to meet the specific needs of seniors as well as people and their families with limited economic resources and who often are underserved. • The UnitedHealthcare team remains actively engaged with individuals impacted by the ongoing state-driven Medicaid eligibility redetermination process. The company’s comprehensive outreach efforts are helping families connect with the right resources to maintain affordable coverage. -- 3 of 13 -- Page 4 of 6 Optum’s health services businesses serve the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, analytics and technology to yield clinical insights, Optum helps improve overall health system performance by optimizing care quality, reducing care costs and improving the consumer experience. Quarterly Financial Performance Three Months Ended September 30, 2023 September 30, 2022 June 30, 2023 Revenues $56.7 billion $46.6 billion $56.3 billion Earnings from Operations $ 3.9 billion $ 3.7 billion $ 3.7 billion Operating Margin 6.9% 7.9% 6.6% • Optum third quarter revenues grew 22% to $56.7 billion. Operating earnings were $3.9 billion compared to $3.7 billion last year. The operating margin of 6.9% compares to 7.9% in the prior year, reflecting investments in services provided to patients and customers to support growth. • Optum Health revenue increased 29% over last year and revenue per consumer served increased 27%, driven by growth in patients served under value-based care arrangements and continued expansion of the types and levels of care provided. The operating results reflect previously noted higher care activity and continued investments to improve patient health outcomes and status. • Optum Insight revenue increased 35% compared to a year ago due to the addition of Change Healthcare and growth across its technology-enabled offerings, which serve health systems, care providers, health plans and life sciences organizations. Optum Insight continues to build and invest in advanced data capabilities to meet the rising needs of its customers. The revenue backlog increased by more than $7 billion to over $31 billion compared to last year. • Optum Rx revenue increased 14% in the third quarter due to growth in serving new clients, expanded relationships with existing clients and continued advancement in the comprehensive scope of pharmacy services offered, including specialty and community-based pharmacy offerings. Adjusted scripts grew to over 383 million compared to 359 million last year. -- 4 of 13 -- Page 5 of 6 About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn. Earnings Conference Call As previously announced, UnitedHealth Group will discuss the company’s results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company’s website (www.unitedhealthgroup.com). Following the call, a webcast replay will be on the Investor Relations page and at https://uhg.com/Replay through October 27, 2023. This earnings release and the Form 8-K dated October 13, 2023, can also be accessed from the Investor Relations page of the company’s website. Non-GAAP Financial Information This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release. Forward-Looking Statements The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements which are intended to take advantage of the “safe harbor” provisions of the federal securities law. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment -- 5 of 13 -- Page 6 of 6 data validation audits; the DOJ’s legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to complete, manage or integrate strategic transactions; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events; failure to attract, develop, retain, and manage the succession of key employees and executives; our investment portfolio performance; impairment of our goodwill and intangible assets; failure to protect proprietary rights to our databases, software and related products; downgrades in our credit ratings; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law. # # # Investor Contact: Media Contact: Zack Sopcak Eric Hausman 952-936-7215 952-936-3963 zack.sopcak@uhg.com eric.hausman@uhg.com -- 6 of 13 -- UNITEDHEALTH GROUP Earnings Release Schedules and Supplementary Information Quarter Ended September 30, 2023 • Condensed Consolidated Statements of Operations • Condensed Consolidated Balance Sheets • Condensed Consolidated Statements of Cash Flows • Supplemental Financial Information - Businesses • Supplemental Financial Information - Business Metrics • Reconciliation of Non-GAAP Financial Measures -- 7 of 13 -- UNITEDHEALTH GROUP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenues Premiums.......................................................................................................................................... $72,339 $64,491 $217,599 $192,457 Products............................................................................................................................................ 10,354 9,190 31,272 28,026 Services ............................................................................................................................................ 8,671 6,700 25,414 19,717 Investment and other income........................................................................................................ 997 513 2,910 1,175 Total revenues ............................................................................................................................ 92,361 80,894 277,195 241,375 Operating costs Medical costs ................................................................................................................................... 59,550 52,635 179,663 157,251 Operating costs................................................................................................................................ 13,855 11,663 41,289 34,773 Cost of products sold...................................................................................................................... 9,423 8,306 28,576 25,389 Depreciation and amortization ...................................................................................................... 1,007 828 2,998 2,418 Total operating costs ................................................................................................................. 83,835 73,432 252,526 219,831 Earnings from operations........................................................................................................... 8,526 7,462 24,669 21,544 Interest expense.............................................................................................................................. (834) (516) (2,416) (1,416) Earnings before income taxes................................................................................................... 7,692 6,946 22,253 20,128 Provision for income taxes............................................................................................................. (1,654) (1,562) (4,784) (4,397) Net earnings .................................................................................................................................. 6,038 5,384 17,469 15,731 Earnings attributable to noncontrolling interests ........................................................................ (197) (122) (543) (372) Net earnings attributable to UnitedHealth Group common shareholders..................... $5,841 $5,262 $16,926 $15,359 Diluted earnings per share attributable to UnitedHealth Group common shareholders ............................................................................................................................ $6.24 $5.55 $18.01 $16.15 Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a) ....................................................................................................................... $6.56 $5.79 $18.95 $16.85 Diluted weighted-average common shares outstanding........................................................... 936 948 940 951 (a) See page 6 for a reconciliation of the non-GAAP measure 1 -- 8 of 13 -- UNITEDHEALTH GROUP CONDENSED CONSOLIDATED BALANCE SHEETS (in millions) (unaudited) September 30, 2023 December 31, 2022 Assets Cash and short-term investments ..................................................................................................................................................... $44,097 $27,911 Accounts receivable, net .................................................................................................................................................................... 20,673 17,681 Other current assets............................................................................................................................................................................ 27,135 23,477 Total current assets................................................................................................................................................................... 91,905 69,069 Long-term investments ....................................................................................................................................................................... 45,474 43,728 Other long-term assets ....................................................................................................................................................................... 144,684 132,908 Total assets.................................................................................................................................................................................... $282,063 $245,705 Liabilities, redeemable noncontrolling interests and equity Medical costs payable......................................................................................................................................................................... $32,792 $29,056 Short-term borrowings and current maturities of long-term debt ................................................................................................. 5,290 3,110 Other current liabilities ........................................................................................................................................................................ 76,097 57,071 Total current liabilities ............................................................................................................................................................... 114,179 89,237 Long-term debt, less current maturities............................................................................................................................................ 58,079 54,513 Other long-term liabilities.................................................................................................................................................................... 15,825 15,608 Redeemable noncontrolling interests ............................................................................................................................................... 4,416 4,897 Equity..................................................................................................................................................................................................... 89,564 81,450 Total liabilities, redeemable noncontrolling interests and equity ........................................................................................... $282,063 $245,705 2 -- 9 of 13 -- UNITEDHEALTH GROUP CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions) (unaudited) Nine Months Ended September 30, 2023 2022 Operating Activities Net earnings ......................................................................................................................................................................................... $17,469 $15,731 Noncash items: Depreciation and amortization ....................................................................................................................................................... 2,998 2,418 Deferred income taxes and other .................................................................................................................................................. (553) (590) Share-based compensation ........................................................................................................................................................... 851 675 Net changes in operating assets and liabilities............................................................................................................................... 13,496 12,505 Cash flows from operating activities.......................................................................................................................................... 34,261 30,739 Investing Activities Purchases of investments, net of sales and maturities ................................................................................................................. (2,850) (4,067) Purchases of property, equipment and capitalized software ........................................................................................................ (2,427) (1,936) Cash paid for acquisitions, net .......................................................................................................................................................... (8,389) (7,154) Other, net .............................................................................................................................................................................................. (721) 50 Cash flows used for investing activities .................................................................................................................................... (14,387) (13,107) Financing Activities Common share repurchases.............................................................................................................................................................. (6,500) (6,000) Dividends paid...................................................................................................................................................................................... (5,023) (4,450) Net change in short-term borrowings and long-term debt............................................................................................................. 5,848 3,806 Other, net .............................................................................................................................................................................................. 1,302 6,478 Cash flows used for financing activities .................................................................................................................................... (4,373) (166) Effect of exchange rate changes on cash and cash equivalents ................................................................................................. 49 4 Increase in cash and cash equivalents ............................................................................................................................................ 15,550 17,470 Cash and cash equivalents, beginning of period............................................................................................................................ 23,365 21,375 Cash and cash equivalents, end of period ...................................................................................................................................... $38,915 $38,845 3 -- 10 of 13 -- UNITEDHEALTH GROUP SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES (in millions, except percentages) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Revenues UnitedHealthcare ............................................................................................................... $69,853 $61,995 $210,552 $186,695 Optum .................................................................................................................................. 56,737 46,559 167,140 134,900 Eliminations ........................................................................................................................ (34,229) (27,660) (100,497) (80,220) Total consolidated revenues ..................................................................................... $92,361 $80,894 $277,195 $241,375 Earnings from Operations UnitedHealthcare ............................................................................................................... $4,592 $3,799 $13,293 $11,447 Optum (a) ............................................................................................................................ 3,934 3,663 11,376 10,097 Total consolidated earnings from operations ......................................................... $8,526 $7,462 $24,669 $21,544 Operating Margin UnitedHealthcare ............................................................................................................... 6.6% 6.1% 6.3% 6.1% Optum .................................................................................................................................. 6.9% 7.9% 6.8% 7.5% Consolidated operating margin ................................................................................ 9.2% 9.2% 8.9% 8.9% Revenues UnitedHealthcare Employer & Individual - Domestic ................................................... $16,854 $15,929 $50,157 $47,318 UnitedHealthcare Employer & Individual - Global ........................................................ 2,417 2,120 6,905 6,500 UnitedHealthcare Employer & Individual - Total .................................................... 19,271 18,049 57,062 53,818 UnitedHealthcare Medicare & Retirement ..................................................................... 32,022 27,895 97,468 85,620 UnitedHealthcare Community & State............................................................................ 18,560 16,051 56,022 47,257 Optum Health ..................................................................................................................... $23,864 $18,463 $70,785 $52,728 Optum Insight ..................................................................................................................... 4,977 3,693 14,147 10,194 Optum Rx ............................................................................................................................ 28,857 25,203 84,921 73,919 Optum Eliminations ........................................................................................................... (961) (800) (2,713) (1,941) (a) Earnings from operations for Optum for the three and nine months ended September 30, 2023 included $1,568 and $4,869 for Optum Health; $1,109 and $2,984 for Optum Insight; and $1,257 and $3,523 for Optum Rx, respectively. Earnings from operations for Optum for the three and nine months ended September 30, 2022 included $1,575 and $4,340 for Optum Health; $1,007 and $2,693 for Optum Insight; and $1,081 and $3,064 for Optum Rx, respectively. 4 -- 11 of 13 -- UNITEDHEALTH GROUP SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS UNITEDHEALTHCARE CUSTOMER PROFILE (in thousands) People Served September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 Commercial - Domestic: Risk-based........................................................................... 8,120 8,035 8,045 8,055 Fee-based ........................................................................... 19,130 19,140 18,640 18,500 Total Commercial - Domestic........................................ 27,250 27,175 26,685 26,555 Medicare Advantage............................................................... 7,645 7,590 7,105 7,035 Medicaid ................................................................................... 8,065 8,355 8,170 8,005 Medicare Supplement (Standardized)................................. 4,345 4,330 4,375 4,370 Total Community and Senior ....................................... 20,055 20,275 19,650 19,410 Total UnitedHealthcare - Domestic Medical............. 47,305 47,450 46,335 45,965 Commercial - Global............................................................... 5,475 5,385 5,360 5,360 Total UnitedHealthcare - Medical................................ 52,780 52,835 51,695 51,325 Supplemental Data Medicare Part D stand-alone........................................... 3,335 3,355 3,295 3,310 OPTUM PERFORMANCE METRICS September 30, 2023 June 30, 2023 December 31, 2022 September 30, 2022 Optum Health Consumers Served (in millions)....................... 103 103 102 101 Optum Insight Contract Backlog (in billions)............................ $31.6 $31.4 $30.0 $24.1 Optum Rx Quarterly Adjusted Scripts (in millions).................. 383 381 370 359 Note: UnitedHealth Group served 152 million unique individuals across all businesses at September 30, 2023. 5 -- 12 of 13 -- UNITEDHEALTH GROUP RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (in millions, except per share data) (unaudited) ADJUSTED NET EARNINGS PER SHARE(a) Three Months Ended September 30, Nine Months Ended September 30, Projected Year Ended December 31, 2023 2022 2023 2022 2023 GAAP net earnings attributable to UnitedHealth Group common shareholders............... $5,841 $5,262 $16,926 $15,359 $22,125 - $22,350 Intangible amortization ............................................................................................................... 392 323 1,178 896 ~1,565 Tax effect of intangible amortization......................................................................................... (96) (92) (292) (233) ~(390) Adjusted net earnings attributable to UnitedHealth Group common shareholders ... $6,137 $5,493 $17,812 $16,022 $23,300 - $23,525 GAAP diluted earnings per share............................................................................................. $6.24 $5.55 $18.01 $16.15 $23.60 - $23.75 Intangible amortization per share ............................................................................................. 0.42 0.34 1.25 0.94 ~1.65 Tax effect per share of intangible amortization....................................................................... (0.10) (0.10) (0.31) (0.24) ~(0.40) Adjusted diluted earnings per share ................................................................................. $6.56 $5.79 $18.95 $16.85 $24.85 - $25.00 ADJUSTED CASH FLOWS FROM OPERATIONS(a) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 GAAP cash flows from operations.............................................................................................................................. $6,902 $18,549 $34,261 $30,739 Add: July CMS premium payments received in June ............................................................................................. 11,808 — — — Less: October CMS premium payments received in September .......................................................................... (11,857) (9,763) (11,857) (9,763) Adjusted cash flows from operations.................................................................................................................. $6,853 $8,786 $22,404 $20,976 (a) Adjusted net earnings per share and adjusted cash flows from operations are non-GAAP financial measures. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company’s acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company’s revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share. Management believes the use of adjusted cash flows from operations provides investors and management with useful information to compare our cash flows from operations for the current period to other periods, when the Company does not receive its monthly payment from the Centers for Medicare and Medicaid Services (CMS) in the applicable quarter. CMS generally remits their monthly payments on the first calendar day of the applicable month. However, if the first calendar day of the month falls on a weekend or a holiday, CMS has typically paid the Company on the last business day of the preceding calendar month. Adjusted cash flows from operating activities presents operating cash flows assuming all CMS payments were received on the first calendar day of the applicable month. 6 -- 13 of 13 --